BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 21500422)

  • 1. New tax credit program aims to revive ailing biotech research.
    Clin Transl Sci; 2010 Oct; 3(5):200. PubMed ID: 21500422
    [No Abstract]   [Full Text] [Related]  

  • 2. Biotechs get $1 billion windfall in R&D tax credits.
    Thiel K
    Nat Biotechnol; 2009 Dec; 27(12):1066. PubMed ID: 20010563
    [No Abstract]   [Full Text] [Related]  

  • 3. Surprise US election results may boost biotech.
    Fox JL
    Nat Biotechnol; 2002 Dec; 20(12):1176. PubMed ID: 12454655
    [No Abstract]   [Full Text] [Related]  

  • 4. Germany contemplates new biotech tax scheme.
    Mitchell P
    Nat Biotechnol; 2003 Jun; 21(6):587-8. PubMed ID: 12776130
    [No Abstract]   [Full Text] [Related]  

  • 5. Windfall warning.
    Nature; 2009 Oct; 461(7266):847-8. PubMed ID: 19829323
    [No Abstract]   [Full Text] [Related]  

  • 6. Can the SBIR and STTR programs advance research goals?
    Ceulemans S; Kolls JK
    Nat Immunol; 2013 Mar; 14(3):192-5. PubMed ID: 23416667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Startups hope federal study fixes SBIR flaws.
    Basu P
    Nat Biotechnol; 2004 Jun; 22(6):644. PubMed ID: 15175671
    [No Abstract]   [Full Text] [Related]  

  • 8. US biotech firms line up for tax credits.
    Ledford H
    Nature; 2010 Jun; 465(7300):854-5. PubMed ID: 20559355
    [No Abstract]   [Full Text] [Related]  

  • 9. Australian states compete for biotech primacy.
    Norrie C
    Nat Biotechnol; 2002 Aug; 20(8):760. PubMed ID: 12147988
    [No Abstract]   [Full Text] [Related]  

  • 10. Japanese council urges reform of funding system.
    Triendl R
    Nat Biotechnol; 2002 Dec; 20(12):1176-8. PubMed ID: 12454656
    [No Abstract]   [Full Text] [Related]  

  • 11. Funding. NIH program fails to launch blacks in biotech.
    Mervis J
    Science; 2015 Nov; 350(6263):896. PubMed ID: 26586739
    [No Abstract]   [Full Text] [Related]  

  • 12. This is not your mentors' NIH--new strategies for research support.
    Rivkees SA
    J Pediatr Endocrinol Metab; 2006 Oct; 19(10):1187-9. PubMed ID: 17172079
    [No Abstract]   [Full Text] [Related]  

  • 13. Do biomaterials really mean business?
    Waltz E
    Nat Biotechnol; 2008 Aug; 26(8):851-3. PubMed ID: 18688229
    [No Abstract]   [Full Text] [Related]  

  • 14. Biotechnology transfer at the National Institutes of Health.
    Chen PS
    Qual Assur; 1993 Dec; 2(4):345-52. PubMed ID: 7952969
    [No Abstract]   [Full Text] [Related]  

  • 15. Assessment: Academic return.
    Eisenstein M
    Nature; 2016 May; 533(7601):S20-1. PubMed ID: 27144604
    [No Abstract]   [Full Text] [Related]  

  • 16. NIH: gearing up for the twenty-first century.
    Baldwin W; McCardle P
    Physiologist; 1997 Jun; 40(3):89, 91-3. PubMed ID: 9230629
    [No Abstract]   [Full Text] [Related]  

  • 17. Biotech crowdfunding paves way for angels.
    Orelli B
    Nat Biotechnol; 2012 Nov; 30(11):1020. PubMed ID: 23138287
    [No Abstract]   [Full Text] [Related]  

  • 18. Following the money at the NIDCR.
    Lunn RH
    Cranio; 2004 Oct; 22(4):263-4. PubMed ID: 15532309
    [No Abstract]   [Full Text] [Related]  

  • 19. Healy attacks NASA's claims; bad news for research budgets.
    Mervis J
    Nature; 1992 Aug; 358(6386):441. PubMed ID: 1641030
    [No Abstract]   [Full Text] [Related]  

  • 20. Limit the number of grants per person.
    Sachs F
    Nature; 1997 Jul; 388(6639):222. PubMed ID: 9230423
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.